The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.23

Today's change+0.22 +0.54%
Updated October 19 11:10 AM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $41.23

Today's change+0.22 +0.54%
Updated October 19 11:10 AM EDT. Delayed by at least 15 minutes.

GlaxoSmithKline PLC Hits New 50-day High

GlaxoSmithKline PLC is up today by (U.S.)$0.22 or 0.54% to (U.S.)$41.23 and setting a new 50-day high. Over the last five days, shares have gained 0.51% and 7.06% year to date. Shares have underperformed the S&P 500 by 19.80% during the last year.

Key company metrics

  • Open(U.S.) $40.99
  • Previous close(U.S.) $41.01
  • High(U.S.) $41.24
  • Low(U.S.) $40.98
  • Bid / Ask(U.S.) $41.23 / (U.S.) $41.23
  • YTD % change+7.06%
  • Volume1,848,813
  • Average volume (10-day)3,771,360
  • Average volume (1-month)3,618,426
  • Average volume (3-month)2,945,060
  • 52-week range(U.S.) $37.20 to (U.S.) $44.54
  • Beta1.01
  • Trailing P/E39.58×
  • P/E 1 year forward14.29×
  • Forward PEG1.24×
  • Indicated annual dividend(U.S.) $2.03
  • Dividend yield4.92%
  • Trailing EPS(U.S.) $1.04
Updated October 19 11:10 AM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue7,3207,3847,5867,542
Total other revenue--------
Total revenue7,3207,3847,5867,542
Gross profit5,1905,0325,2575,099
Total cost of revenue2,1302,3522,3292,443
Total operating expense7,3205,6666,9916,111
Selling / general / administrative2,2942,3472,4762,232
Research & development1,0539191,017876
Depreciation / amortization11111011
Interest expense (income), net operating--------
Unusual expense (income)1,9301191,276656
Other operating expenses, total-98-82-117-107
Operating income01,7185951,431
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-1781,5504231,274
Income after tax-861,223317885
Income tax, total-92327106389
Net income-1801,046257808
Total adjustments to net income--------
Net income before extra. items-1801,046257808
Minority interest-94-177-60-77
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-1801,046257808
Inc. avail. to common incl. extra. items-1801,046257808
Diluted net income-1801,046257809
Dilution adjustment----01
Diluted weighted average shares4,8774,8774,9574,902
Diluted EPS excluding extraordinary itemsvalue per share-0.040.210.050.17
Dividends per sharevalue per share0.000.190.230.19
Diluted normalized EPSvalue per share0.260.230.250.30